Vrtx stock price target

Abrahams kept his sector perform rating and 347 price target on VRTX stock. Last Updated: Jun 13, 2024 1 day ago · Argus Research's Jasper Hellweg raised their price target on Vertex Pharmaceuticals (NASDAQ: VRTX) by 18. 06 USD. 0 as of 2024-05-17, the highest VRTX price target in the range was $559. 3 Months Ago. 13. 55 billion to $10. -8. 2 days ago · Current. 21 hours ago · In 2024, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is expecting revenue in the range of $10. 1 Month Ago. The analyst maintained their Strong Buy rating on the stock. 00 USD and a min estimate of 325. RBC Capital analyst Brian Abrahams maintained a Sector Perform rating. Cons: No Dividends: Although this is no dealbreaker, the fact that VRTX does not pay a Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat. 98 -3. View Vertex Pharmaceuticals Incorporated VRTX investment & stock information. Oct 9, 2023 · Based on VRTX's consensus FY2025 adj EPS estimates of $17. 00 and a low estimate of $379. The firm focuses on development and commercializing therapies for the VRTX stock analysts forecast earnings of $15. 00 and a high estimate of 10. 00 to a high of . VRTX Stock: An Alternative To Opioids Vertex is testing its drug in people with acute and neuropathic pain. 50 in Dec 31, 1997. Show More Ratings. Vertex Pharmaceuticals stock was originally listed at a price of $16. 97. (VRTX) is a Top Growth Stock for the Long 1 day ago · Use the Zacks Rank and Style Scores to find out is VRTX is right for your portfolio. The research report from Evercore ISI has downgraded the stock from Outperform to In-line, with a price target set at $438. Is Vortex Energy Corp. 75 versus the current price of Jun 5, 2024 · In another report released on May 31, BMO Capital also maintained a Buy rating on the stock with a $500. Hellweg attributed the price target increase to Vertex Pharmaceuticals' continued pipeline progress, M&A activity, and financial strength. 55, we are also looking at a long-term price target of $425. Jun. com. The company’s shares May 8, 2024 · Vertex Pharmaceuticals price target raised to $456 from $450 at Piper Sandler Vertex Pharmaceuticals affirms FY4 revenue view of $10. Royal Bank of Canada currently has a sector perform rating on the pharmaceutical company’s stock. 21 The price target is an average of many targets provided by (VRTX) Price Target Increased by 11. RBC Capital was out with a bearish note for the firm in June 2024 when it cut Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s share price target to $421 from $424 and kept a Sector Perform Nov 6, 2023 · Brokerage Recommendation Trends for VRTX. The 6 analysts with 12-month price forecasts for BTAI stock have an average target of 6. View comments. ABT : 107. Price Target $ 480. 14% from its Dec 14, 2023 · Vertex Pharmaceuticals (VRTX) Maxim Group analyst Naz Rahman maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $430. 00, and a low estimate of $371. 3% from $465 to $550 on 2024/06/17. 5 days ago · According to 24 analysts, the average rating for VRTX stock is "Buy. ’s price is currently Overvalued. Canaccord Genuity Downgrades Vertex Pharmaceuticals to Sell From Hold, Adjusts Price Target to $379 From $332 Jun 12, 2024 · Several other brokerages also recently commented on VRTX. 76, implying a more than decent upside potential of +19. Share your ideas and get valuable insights from the community of like minded traders and investors This would represent a 22. 00 to $500. (Symbol: VRTX) have crossed above the average analyst 12-month target price of $392. 00 and Vertex Pharmaceuticals Incorpor (VRTX) stock forecast and price target. Vertex Pharmaceuticals Inc (VRTX) 441. 35%) Despite the expected growth, however, the consensus analyst price target for the stock is just under $395, which implies that Wall Street expects the stock Jan 30, 2024 · On the stock market today, VRTX stock climbed 2. " The 12-month stock price forecast is $445. 39. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. VRTX's current price target is $438. 48. 37% from the current stock price of 475. The company’s shares closed last View Vertiv Holdings Co. 20. Feb 20, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $438. 73: VRTX will Get the latest Vertex Pharmaceuticals Incorporated (VRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment May 10, 2024 · Vertex Pharmaceuticals Incorporated analysts consensus, targets, ratings and recommendations | Nasdaq: VRTX | Nasdaq Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing. 27 (+0. Find the latest Vertex Pharmaceuticals Incorpor VRTX analyst stock forecast, price target, and recommendation trends with in View VRTX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. 0 while the lowest VRTX price target in the range was $325. 53 per share, the total value of Vertex Pharmaceuticals stock (market capitalization) is $124. 5 days ago · Stock Price Forecast. Vertex Pharmaceuticals price target raised to $424 from $417 at RBC Capital. Feb 6, 2024 · In a report issued on January 22, BTIG also maintained a Buy rating on the stock with a $392. (VRTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. 50, your return over the last 26 years would have Vertex Pharmaceuticals Insider Sold Shares Worth $3,483,664, According to a Recent SEC Filing. See the top stocks recommended by analysts >> Vertex Pharmaceuticals (VRTX) Oct 12, 2023 · Risinger reiterated his 442 price target and outperform rating on VRTX stock. Track Vertex Pharmaceuticals, Inc. 23, with a high estimate of 559. 91 if it maintains its current 10-year average growth rate. 00 expecting VRTX to fall Dec 10, 2023 · In another report released on December 8, Barclays also maintained a Buy rating on the stock with a $415. Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497. RBC Adjusts Price Target on Vertex Pharmaceuticals to $421 From $424. The midpoint of this range would represent an 8% revenue growth on Nov 7, 2023 · RBC Capital cut the price target on Vertex Pharmaceuticals from $350 to $347. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $437. 11. 9. A list of analyst ratings for Vertex Pharmaceuticals (VRTX) stock. 00. released its earnings results on May 30, 2024. The average target predicts an increase of 337. 4 K‬. 87, changing hands for $385. Company Overview; 1 Valuation; VRTX) Price Target To US$452 Feb 07. Price Target What are analysts forecasts for Vertex Pharmaceuticals stock? The 95 analysts offering price forecasts for Vertex Pharmaceuticals have a median target of 380. When a stock Jun 11, 2024 · A. Transcript : Vertex Pharmaceuticals Incorporated Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 11:20 AM. Get the latest Vertex Pharmaceuticals Incorporated VRTX detailed stock quotes, stock data, Real May 17, 2024 · The median VRTX price target (a different metric than the average or mean) was $450. 1989. The analyst firm set a price target for 421. Zacks Investment Research. comes to $102. Ex-dividend date. All. 96% from the current stock price of 1. Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing. The company reported -C$0. 73, with a high forecast of $315. 1, along with a high estimate of $559. 18d ago. 23 USD with a max estimate of 577. Reshma Kewalramani. Vertex Pharmaceuticals, Inc. Jun 12, 2024 · The 20 analysts with 12-month price forecasts for VRTX stock have an average target of 445. See today’s best-performing stocks on TipRanks >> Jun 12, 2024 · Stock analysis for Vertex Pharmaceuticals Inc (VRTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Still, Raymond kept his buy rating and 450 price target on VRTX stock. 1% upside from current levels. Get the latest Zacks research report on VRTX — FREE. 33% from the latest price. 00 expecting VRTX to fall to within According to analysts, VRTX price target is 467. 75 billion. Morningstar set a far Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing. No data available 5 days ago · Downgrades. 37. Stock Price Target. Similarly, RBC Capital Markets Jan 30, 2024 · William Blair analyst Myles Minter has reiterated their bullish stance on VRTX stock, giving a Buy rating today. 77% over the next twelve months. 94 Vanguard Total Stock Market Index Fund Investor Shares holds 8,034K shares 2 days ago · Website. analyst estimates, including VRTX earnings per share estimates and analyst recommendations. When a stock Nov 14, 2023 · Find the latest Vertex Pharmaceuticals Incorpor (VRTX) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Raising target price to $420 Assess the Vortex Energy stock price estimates. vrtx. 83%. (VRTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. 4. $4. 69, a high estimate of $550. 96, changing hands for $404. Vertex Pharmaceuticals price target raised to $477 from $466 at UBS. 27%) Stock market today: Asian shares decline after a mixed post-holiday session on Wall Street Associated Press - Tue May 28, 11:12PM CDT. May 6, 2024 · With a volume of 374,195, the price of VRTX is up 0. The Fly. MT. 00 and a low of $285. See the top stocks recommended by analysts >> Jun 5, 2024 · NasdaqGS:VRTX Stock Report. Vertex Pharmaceuticals price target raised to $529 from $511 at Leerink. 79. 03 per share and $9. 5, with a low estimate of 364 and a high estimate of 559. See today’s best-performing stocks on TipRanks >> Feb 10, 2024 · Vertex Pharmaceuticals (VRTX 0. 00, with a low estimate of 4. 27% to 474. www. 73 (VRTX) Stock Quote, History and News - Yahoo Finance According to analysts, VRTX price target is 466. 2% at $401. Feb 6, 2024. Jun 14 8:28am ET Vertiv Holdings price target raised to $105 2 days ago · Insights from analysts' 12-month price targets are revealed, presenting an average target of $455. Nov 8, 2023 · Vertex Pharmaceuticals (VRTX) Truist Financial analyst Robyn Karnauskas maintained a Buy rating on Vertex Pharmaceuticals on November 6 and set a price target of $456. VRTX. 025 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0. Check if this forecast comes true in a year, meanwhile watch Vertex Pharmaceuticals Incorporated stock price chart and keep track of the current situation with VRTX news and stock market news. (NASDAQ:VRTX) stock from “an In-line” to “an Outperform”. * Price Target & Stock While the F1 consensus estimate and revision is a key driver of stock prices 1 day ago · Billion Dollar Secret. View the latest Vertex Pharmaceuticals Inc. 00 to $450. […] Dec 4, 2023 · Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. Stock Forecast Mar 21, 2023 · According to 10 analyst offering 12-month price targets in the last 3 months, Vertex Pharmaceuticals has an average price target of $322. Follow Allison Gatlin on X, Nov 14, 2023 · Currently, the analyst consensus on Vertex Pharmaceuticals is a Moderate Buy with an average price target of $392. Price Target Dec 14, 2023 · In recent trading, shares of Vertex Pharmaceuticals, Inc. 5 with a high of $374. FIGI. 025. In depth view into Vertex Pharmaceuticals Price Target including historical data from 1991, charts and stats. It will be key to watch how Vertex tries to capitalize Get the latest Vortex Energy Corp (VRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The company’s shares closed 1 day ago · Price Target. overvalued? According to Wall Street analysts Vortex Energy Corp. The range of stock forecasts for Vertex is 328. Oct 16, 2023 · Within the last quarter, Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst ratings: These 20 analysts have an average price target of $374. Founded. 00: Low: $325. For what it's worth, UBS has a really superior 12-month price target of $419 for VRTX, but CFRA is at only $388, Reuters is at $387. The average target predicts a decrease of -6. (InvestorPlace) 09:45AM. News. 49. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst 12-Month VRTX price targets. By comparison, VRTX has a P/B of 5. The analyst firm set a price target for $421. 97/share. 00 and gave the stock a buy rating in a research note The average stock forecast for Vertex Pharmaceuticals Inc (VRTX) is 477. 24 (-0. Class A VRT stock quote prices, financial information, real-time forecasts, and company news from CNN. VRTX US. 468. Set a price target alert OK. 5, which is a decrease of -7. 3 Cheap Biotech Stocks to Buy Now: May 2024. May 8, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price hoisted by Royal Bank of Canada from $417. 2% to 404. Vertex Pharmaceuticals Stock Prediction 2030. VRTX Stock News Vertex Pharmaceuticals Incorporated. 58, which is a 3. The company’s 5 days ago · Detailed statistics for Vertex Pharmaceuticals Incorporated (VRTX) stock, including valuation metrics, financial numbers, share information and more. Those same analysts give the stock an average rating of Buy. 00: Average: $467. 75B Vertex Pharmaceuticals reports Q1 EPS $4. N/A. Based on the ratings of 38, the consensus recommendation for Vertex is BUY Feb 9, 2024 · Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Nvidia stock began trading Monday after its 10-for-1 stock split and received price-target hikes from three Wall Street analysts. 25 - 605. Based on short-term price targets offered by 10 analysts, the average price target for Vertiv Holdings Co. 09. Nov 7, 2023 · In recent trading, shares of Vertex Pharmaceuticals, Inc. On Tuesday, RBC Capital adjusted its price target on shares of Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX 6 days ago · Download Vertex Pharmaceuticals Inc. 76/share. The company’s shares closed last Monday Jun 12, 2024 · With Vertex Pharmaceuticals stock trading at $481. Feb 16, 2024 · Analysts who follow Vertex Pharmaceuticals Incorporated (VRTX) on average expect it to climb 5. Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by RBC Capital on June 11, 2024. 00 to $424. To read this article on Zacks. 86 billion in sales. Jun 11, 2024 · The latest price target for . Nov 6, 2023 · Check price target & stock forecast for Vertex here>>> (VRTX) : Free Stock Analysis Report. 00 and a low forecast of $199. 26B. 70 (0. 1b. Full year 2023 earnings Nov 6, 2023 · Vertex Pharmaceuticals (VRTX) TD Cowen analyst Phil Nadeau maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $390. 0, with a standard deviation of $57. 1y target est. Jun 7, 2024 · According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for MarketAxess is $249. Check price target & stock forecast for Vertex here>>> While the ABR calls for buying Vertex, it may not be wise to make an investment decision solely Vertex shares target trimmed with Sector Perform by RBC Capital. 49%) DXCM : 116. (Symbol: VRTX) have crossed above the average analyst 12-month target price of $383. 5 days ago · View Vertex Pharmaceuticals Incorporated VRTX stock quote prices, financial information, real-time forecasts, and company news from CNN. For what it's worth, UBS has a really superior 12-month price target of $449 for VRTX, but CFRA is at only $427, Reuters is at $400. Jan 8, 2024 · Vertex Pharmaceuticals (VRTX) In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Vertex Pharmaceuticals, with a price target of $450. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people Jun 5, 2024 · Evercore ISI raised the price target for the Vertex Pharmaceuticals, Inc. 91 (+3. 2% from current levels Vortex Energy Corp. Nov 17, 2023 · Find out why VRTX stock is a Buy. Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). Market Cap: US$124. com click here. Add to watchlist. (Zacks) 05:43AM. Vertex Pharmaceuticals Inc. Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock. 68: Current Price: $480. 15 Wall Street analysts that have issued a 1 year VRTX price target, the average VRTX price target is $468. Open. 00 USD. The consensus rating for MarketAxess stock is Hold based on the current 2 sell ratings, 6 hold ratings and 3 buy ratings for MKTX. 68 USD with a max estimate of 577. 704. 5,400. BBG000C1S2X2. The latest price target for Vertex Pharmaceuticals ( NASDAQ: VRTX) was reported by RBC Capital on Tuesday, June 11, 2024. Nov 15, 2023 · Vertex Pharmaceuticals (VRTX) Canaccord Genuity analyst Whitney Ijem maintained a Hold rating on Vertex Pharmaceuticals yesterday and set a price target of $336. 17d ago. 00 and the lowest VRTX stock price forecast at $371. 00 in a report issued on Tuesday morning, Benzinga reports. Sep 20, 2023 · Click here to find out why VRTX stock is rated a buy. historical stock charts and prices, analyst ratings, financials, and today’s real-time VRTX stock price. According to . If this Vertex Pharmaceuticals stock prediction for 2030 materializes, VRTX stock will grow 236. The forecasts range from a low of $89. 73 1. stock data: historical VRTX stock prices from MarketWatch. Several other research analysts have also recently issued reports on VRTX. Press releases. If you had invested in Vertex Pharmaceuticals stock at $16. Guggenheim raised their target price on Vertex Pharmaceuticals from $445. Surpassing the previous average May 7, 2024 · In another report released on May 3, Bank of America Securities also maintained a Buy rating on the stock with a $550. 00 price target. 89%. In 2030, the Vertex Pharmaceuticals stock will reach $ 1,591. 08. (VRTX): $480. TD Cowen also maintained a Buy rating on the stock with a $450. 39% increase in the VRTX stock price. 89 ( -0. $436 → $438. Learn why top analysts are making this stock forecast for Vertex Pharmaceuticals at MarketBeat. 87, with the highest VRTX stock price forecast at $559. 87% ) USD | NASDAQ | May 21, 16:00 Jun 1, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price raised by BMO Capital Markets from $480. 84%) VRTX : 484. 00 in a report issued on Friday morning, Benzinga reports. Jun 4, 2024 · Valuation: With a fair stock price target of $566, there's significant upside potential from current levels. 55B-$10. Abrahams kept his sector perform rating and 397 price target on VRTX stock. Dec 13, 2023 · On today's stock market, VRTX stock surged 13. The rating was released on April 11, 2024, according to finviz. 85 USD. High: $577. Feb 3, 2017 · Find the latest Vertex Pharmaceuticals Inc (VRTX) stock forecast, 12-month price target, predictions and analyst recommendations. 35%) Quote Time: Jun 14 4:00pm . 70. 4% to close at 446. This price target corresponds to an upside of 5. Employees (FY) ‪5. da sk sh tx ak hh zj sn wg qi